Antiviral properties of two trimeric recombinant gp41 proteins
<p>Abstract</p> <p>Background</p> <p>As it is the very first step of the HIV replication cycle, HIV entry represents an attractive target for the development of new antiviral drugs. In this context, fusion inhibitors are the third class of anti-HIV drugs to be used for...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-03-01
|
| Series: | Retrovirology |
| Online Access: | http://www.retrovirology.com/content/3/1/16 |